Literature DB >> 32466889

Mechanistic Biomarkers Informative of Both Cancer and Cardiovascular Disease: JACC State-of-the-Art Review.

Vivek Narayan1, Elizabeth W Thompson2, Biniyam Demissei3, Jennifer E Ho4, James L Januzzi5, Bonnie Ky6.   

Abstract

Cardiovascular disease (CVD) and cancer are leading causes of morbidity and mortality worldwide. Although conventionally managed as separate disease processes, recent research has lent insight into compelling commonalities between CVD and cancer, including shared mechanisms for disease development and progression. In this review, the authors discuss several pathophysiological processes common to both CVD and cancer, such as inflammation, resistance to cell death, cellular proliferation, neurohormonal stress, angiogenesis, and genomic instability, in an effort to understand common mechanisms of both disease states. In particular, the authors highlight key circulating and genomic biomarkers associated with each of these processes, as well as their associations with risk and prognosis in both cancer and CVD. The purpose of this state-of-the-art review is to further our understanding of the potential mechanisms underlying cancer and CVD by contextualizing pathways and biomarkers common to both diseases.
Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  biomarkers; cancer; cardio-oncology; cardiovascular disease

Mesh:

Substances:

Year:  2020        PMID: 32466889      PMCID: PMC7261288          DOI: 10.1016/j.jacc.2020.03.067

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  109 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

2.  Growth-differentiation factor-15 is an independent marker of cardiovascular dysfunction and disease in the elderly: results from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) Study.

Authors:  Lars Lind; Lars Wallentin; Tibor Kempf; Heike Tapken; Anja Quint; Bertil Lindahl; Sylvia Olofsson; Per Venge; Anders Larsson; Johannes Hulthe; Anders Elmgren; Kai C Wollert
Journal:  Eur Heart J       Date:  2009-06-26       Impact factor: 29.983

3.  Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial.

Authors:  Paul M Ridker; Jean G MacFadyen; Brendan M Everett; Peter Libby; Tom Thuren; Robert J Glynn
Journal:  Lancet       Date:  2017-11-13       Impact factor: 79.321

4.  From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus.

Authors:  Kiran Musunuru; Alanna Strong; Maria Frank-Kamenetsky; Noemi E Lee; Tim Ahfeldt; Katherine V Sachs; Xiaoyu Li; Hui Li; Nicolas Kuperwasser; Vera M Ruda; James P Pirruccello; Brian Muchmore; Ludmila Prokunina-Olsson; Jennifer L Hall; Eric E Schadt; Carlos R Morales; Sissel Lund-Katz; Michael C Phillips; Jamie Wong; William Cantley; Timothy Racie; Kenechi G Ejebe; Marju Orho-Melander; Olle Melander; Victor Koteliansky; Kevin Fitzgerald; Ronald M Krauss; Chad A Cowan; Sekar Kathiresan; Daniel J Rader
Journal:  Nature       Date:  2010-08-05       Impact factor: 49.962

5.  Circulating interleukin-6 level is a prognostic marker for survival in advanced nonsmall cell lung cancer patients treated with chemotherapy.

Authors:  Chin Hao Chang; Chin Fu Hsiao; Yu Min Yeh; Gee Chen Chang; Ying Huang Tsai; Yuh Min Chen; Ming Shyan Huang; Hui Ling Chen; Yao Jen Li; Pan Chyr Yang; Chien Jen Chen; Chao A Hsiung; Wu Chou Su
Journal:  Int J Cancer       Date:  2012-10-29       Impact factor: 7.396

6.  Decreased expression of Mac-2 (carbohydrate binding protein 35) and loss of its nuclear localization are associated with the neoplastic progression of colon carcinoma.

Authors:  M M Lotz; C W Andrews; C A Korzelius; E C Lee; G D Steele; A Clarke; A M Mercurio
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

7.  Heart Failure Stimulates Tumor Growth by Circulating Factors.

Authors:  Wouter C Meijers; Manuel Maglione; Stephan J L Bakker; Rupert Oberhuber; Lyanne M Kieneker; Steven de Jong; Bernhard J Haubner; Wouter B Nagengast; Alexander R Lyon; Bert van der Vegt; Dirk J van Veldhuisen; B Daan Westenbrink; Peter van der Meer; Herman H W Silljé; Rudolf A de Boer
Journal:  Circulation       Date:  2018-08-14       Impact factor: 29.690

8.  Serial measurement of galectin-3 in patients with chronic heart failure: results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study.

Authors:  Shweta R Motiwala; Jackie Szymonifka; Arianna Belcher; Rory B Weiner; Aaron L Baggish; Patrick Sluss; Hanna K Gaggin; Anju Bhardwaj; James L Januzzi
Journal:  Eur J Heart Fail       Date:  2013-05-10       Impact factor: 15.534

Review 9.  Common Cardiovascular Complications of Cancer Therapy: Epidemiology, Risk Prediction, and Prevention.

Authors:  Vivek Narayan; Bonnie Ky
Journal:  Annu Rev Med       Date:  2018-01-29       Impact factor: 13.739

Review 10.  GDF15 and Growth Control.

Authors:  Paul J Emmerson; Kevin L Duffin; Sudhakar Chintharlapalli; Xinle Wu
Journal:  Front Physiol       Date:  2018-11-27       Impact factor: 4.566

View more
  15 in total

1.  Coronary artery calcium is associated with long-term mortality from lung cancer: Results from the Coronary Artery Calcium Consortium.

Authors:  Omar Dzaye; Philipp Berning; Zeina A Dardari; Daniel S Berman; Matthew J Budoff; Michael D Miedema; Khurram Nasir; Alan Rozanski; John A Rumberger; Leslee J Shaw; Martin Bødtker Mortensen; Seamus P Whelton; Michael J Blaha
Journal:  Atherosclerosis       Date:  2021-10-18       Impact factor: 5.162

2.  IL-6 secretion of CD4+ T cells stimulated by LC3-positive extracellular vesicles in human epithelial ovarian cancer.

Authors:  Xiu-Lin Zhu; Hao-Jue Wang; Xu-Ru Wang; Di Wu; Xuan Ji; Li Xu; Qi Yang; Jie-Ying Guo; Yan Rong; Ning Pan; Yun-Lang Cai
Journal:  Clin Transl Oncol       Date:  2022-07-23       Impact factor: 3.340

Review 3.  Therapeutic targeting of BAG3: considering its complexity in cancer and heart disease.

Authors:  Jonathan A Kirk; Joseph Y Cheung; Arthur M Feldman
Journal:  J Clin Invest       Date:  2021-08-16       Impact factor: 19.456

Review 4.  Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers.

Authors:  Michela Chianca; Giorgia Panichella; Iacopo Fabiani; Alberto Giannoni; Serena L'Abbate; Alberto Aimo; Annamaria Del Franco; Giuseppe Vergaro; Chrysanthos Grigoratos; Vincenzo Castiglione; Carlo Maria Cipolla; Antonella Fedele; Claudio Passino; Michele Emdin; Daniela Maria Cardinale
Journal:  Front Cardiovasc Med       Date:  2022-07-06

Review 5.  The Translation and Commercialisation of Biomarkers for Cardiovascular Disease-A Review.

Authors:  Soloman Saleh; Jacob George; Katharine A Kott; Peter J Meikle; Gemma A Figtree
Journal:  Front Cardiovasc Med       Date:  2022-06-02

6.  Atrial Cardiomyopathy Predicts Worse Outcome in Patients With Lung Cancer.

Authors:  Mengdi Ren; Yuyan Ma; Meng Wei; Yuye Ning; Hui Liu; Xue Shi; Yu Yao; Fengwei Guo
Journal:  Front Cardiovasc Med       Date:  2022-07-01

7.  Pooled Cohort Equations and the competing risk of cardiovascular disease versus cancer: Multi-Ethnic study of atherosclerosis.

Authors:  Seamus P Whelton; Catherine Handy Marshall; Miguel Cainzos-Achirica; Omar Dzaye; Roger S Blumenthal; Khurram Nasir; Robyn L McClelland; Michael J Blaha
Journal:  Am J Prev Cardiol       Date:  2021-06-14

8.  Coronary artery calcium is associated with increased risk for lung and colorectal cancer in men and women: the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Omar Dzaye; Philipp Berning; Zeina A Dardari; Martin Bødtker Mortensen; Catherine Handy Marshall; Khurram Nasir; Matthew J Budoff; Roger S Blumenthal; Seamus P Whelton; Michael J Blaha
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2022-04-18       Impact factor: 9.130

9.  Cardiovascular Risk Factors are Associated with Future Cancer.

Authors:  Emily S Lau; Samantha M Paniagua; Elizabeth Liu; Manol Jovani; Shawn X Li; Katherine Takvorian; Navin Suthahar; Susan Cheng; Greta L Splansky; James L Januzzi; Thomas J Wang; Ramachandran S Vasan; Bernard Kreger; Martin G Larson; Daniel Levy; Rudolf A de Boer; Jennifer E Ho
Journal:  JACC CardioOncol       Date:  2021-03-16

10.  N-Terminal Pro Brain Natriuretic Peptide, sST2, and Galectin-3 Levels in Breast Cancer Survivors.

Authors:  Shruti Rajesh Patel; Joerg Herrmann; Robert A Vierkant; Janet E Olson; Fergus J Couch; Antonious Hazim; Jeff A Sloan; Charles L Loprinzi; Kathryn J Ruddy
Journal:  J Clin Med       Date:  2021-07-27       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.